Abstract
Studies assessing the risk of congenital malformations associated with the treatment of asthma during the first trimester of pregnancy are few, have limited power and support continuation of treatment.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Abnormalities, Drug-Induced / etiology*
-
Anti-Asthmatic Agents / adverse effects*
-
Female
-
Humans
-
Maternal-Fetal Exchange
-
Pregnancy